Most cited documents in this series:

Year	Title	Cited
1999	The contingent valuation method in health care RePEc:eee:hepoli:v:47:y:1999:i:2:p:97-123 [Citation Analysis]	47
2000	Review of the literature on reference pricing RePEc:eee:hepoli:v:54:y:2000:i:2:p:87-123 [Citation Analysis]	27
1993	The trade-off between severity of illness and treatment effect in cost-value analysis of health care RePEc:eee:hepoli:v:24:y:1993:i:3:p:227-238 [Citation Analysis]	26
1991	Economic evaluation in health care: Is there a role for cost-benefit analysis? RePEc:eee:hepoli:v:17:y:1991:i:1:p:1-23 [Citation Analysis]	20
2003	Risk adjustment in Switzerland RePEc:eee:hepoli:v:65:y:2003:i:1:p:63-74 [Citation Analysis]	15
2003	The economic impact of malaria in Africa: a critical review of the evidence RePEc:eee:hepoli:v:63:y:2003:i:1:p:17-36 [Citation Analysis]	15
2005	The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time RePEc:eee:hepoli:v:71:y:2005:i:1:p:23-42 [Citation Analysis]	14
1997	Household income and health care expenditures in Mexico RePEc:eee:hepoli:v:40:y:1997:i:3:p:237-255 [Citation Analysis]	14
2004	Incentives and pharmaceutical reimbursement reforms in Spain RePEc:eee:hepoli:v:67:y:2004:i:2:p:149-165 [Citation Analysis]	14
2006	Life expectancy and health care expenditures: A new calculation for Germany using the costs of dying RePEc:eee:hepoli:v:75:y:2006:i:2:p:178-186 [Citation Analysis]	13
2003	Needs for further improvement: risk adjustment in the German health insurance system RePEc:eee:hepoli:v:65:y:2003:i:1:p:21-35 [Citation Analysis]	13
1999	Public views on health care rationing: a group discussion study RePEc:eee:hepoli:v:49:y:1999:i:1-2:p:63-74 [Citation Analysis]	12
2005	Tackling excessive waiting times for elective surgery: a comparative analysis of policies in 12 OECD countries RePEc:eee:hepoli:v:72:y:2005:i:2:p:201-215 [Citation Analysis]	12
2000	On hypothetical bias and calibration in cost-benefit studies RePEc:eee:hepoli:v:52:y:2000:i:1:p:53-70 [Citation Analysis]	12
2002	A typology for provider payment systems in health care RePEc:eee:hepoli:v:60:y:2002:i:3:p:255-273 [Citation Analysis]	12
1997	Willingness to pay for health insurance in a developing economy. A pilot study of the informal sector of Ghana using contingent valuation RePEc:eee:hepoli:v:42:y:1997:i:3:p:223-237 [Citation Analysis]	12
2000	A qualitative study of the extent to which health gain matters when choosing between groups of patients RePEc:eee:hepoli:v:51:y:2000:i:1:p:19-30 [Citation Analysis]	11
1996	EuroQol: the current state of play RePEc:eee:hepoli:v:37:y:1996:i:1:p:53-72 [Citation Analysis]	10
1997	Patients willingness to pay for autologous blood donation RePEc:eee:hepoli:v:40:y:1997:i:1:p:1-12 [Citation Analysis]	10
2002	Free choice of sickness funds in regulated competition: evidence from Germany and The Netherlands RePEc:eee:hepoli:v:60:y:2002:i:3:p:235-254 [Citation Analysis]	10
1995	Who cares about cost? Does economic analysis impose or reflect social values? RePEc:eee:hepoli:v:34:y:1995:i:2:p:79-94 [Citation Analysis]	10
2004	Technical efficiency in the use of health care resources: a comparison of OECD countries RePEc:eee:hepoli:v:69:y:2004:i:1:p:55-72 [Citation Analysis]	10
2003	Risk adjustment and risk selection on the sickness fund insurance market in five European countries RePEc:eee:hepoli:v:65:y:2003:i:1:p:75-98 [Citation Analysis]	9
2003	Service production and contract choice in primary physician services RePEc:eee:hepoli:v:66:y:2003:i:1:p:73-93 [Citation Analysis]	9
1995	Value for money? A contingent valuation study of the optimal size of the Swedish health care budget RePEc:eee:hepoli:v:34:y:1995:i:2:p:135-143 [Citation Analysis]	9
2004	The impact of ageing on hospital care and long-term care--the example of Germany RePEc:eee:hepoli:v:67:y:2004:i:1:p:57-74 [Citation Analysis]	9
2002	Policy relevant determinants of health: an international perspective RePEc:eee:hepoli:v:60:y:2002:i:3:p:201-218 [Citation Analysis]	9
2006	Comparing hospital cost efficiency between Norway and Finland RePEc:eee:hepoli:v:77:y:2006:i:3:p:268-278 [Citation Analysis]	9
1995	The use of economic evaluation in health care: Australian decision makers perceptions RePEc:eee:hepoli:v:31:y:1995:i:2:p:103-110 [Citation Analysis]	9
1987	Cost of illness studies: An aid to decision-making? RePEc:eee:hepoli:v:8:y:1987:i:3:p:317-323 [Citation Analysis]	9
1998	Primary health care meets the market in China and Vietnam RePEc:eee:hepoli:v:44:y:1998:i:3:p:233-252 [Citation Analysis]	9
2002	Reforming Chinas urban health insurance system RePEc:eee:hepoli:v:60:y:2002:i:2:p:133-150 [Citation Analysis]	9
1995	Evaluating the effects of GP remuneration: problems and prospects RePEc:eee:hepoli:v:31:y:1995:i:3:p:183-195 [Citation Analysis]	9
2004	Willingness to pay for public health care: a comparison of two approaches RePEc:eee:hepoli:v:70:y:2004:i:2:p:217-228 [Citation Analysis]	8
2001	Health-related quality of life by disease and socio-economic group in the general population in Sweden RePEc:eee:hepoli:v:55:y:2001:i:1:p:51-69 [Citation Analysis]	8
2006	Socioeconomic determinants of regional differences in outpatient antibiotic consumption: Evidence from Switzerland RePEc:eee:hepoli:v:78:y:2006:i:1:p:77-92 [Citation Analysis]	8
2003	The reliability and validity of willingness to pay surveys for reproductive health pricing decisions in developing countries RePEc:eee:hepoli:v:63:y:2003:i:1:p:37-47 [Citation Analysis]	8
2001	Scope and scale insensitivities in a contingent valuation study of risk reductions RePEc:eee:hepoli:v:57:y:2001:i:2:p:141-153 [Citation Analysis]	8
1996	Modelling valuations for health states: the effect of duration RePEc:eee:hepoli:v:38:y:1996:i:3:p:189-203 [Citation Analysis]	8
2003	Belgium: risk adjustment and financial responsibility in a centralised system RePEc:eee:hepoli:v:65:y:2003:i:1:p:5-19 [Citation Analysis]	8
2005	Process utility from providing informal care: the benefit of caring RePEc:eee:hepoli:v:74:y:2005:i:1:p:85-99 [Citation Analysis]	8
2004	The impact of urban health insurance reform on hospital charges: a case study from two cities in China RePEc:eee:hepoli:v:68:y:2004:i:2:p:197-209 [Citation Analysis]	7
1998	The German health care system and health care reform RePEc:eee:hepoli:v:43:y:1998:i:2:p:171-194 [Citation Analysis]	7
1994	Cost containment and health care reform: a study of the European Union RePEc:eee:hepoli:v:28:y:1994:i:2:p:89-132 [Citation Analysis]	7
2001	The relationship between per capita income and diffusion of medical technologies RePEc:eee:hepoli:v:58:y:2001:i:1:p:1-14 [Citation Analysis]	7
2002	Fairness, accountability for reasonableness, and the views of priority setting decision-makers RePEc:eee:hepoli:v:61:y:2002:i:3:p:279-290 [Citation Analysis]	7
1996	The monopolistic integrated model and health care reform: the Swedish experience RePEc:eee:hepoli:v:37:y:1996:i:1:p:19-33 [Citation Analysis]	7
2006	Is decentralisation the real solution?: A three country study RePEc:eee:hepoli:v:77:y:2006:i:1:p:113-120 [Citation Analysis]	7
2009	Economic incentives in general practice: The impact of pay-for-participation and pay-for-compliance programs on diabetes care RePEc:eee:hepoli:v:90:y:2009:i:2-3:p:140-148 [Citation Analysis]	7
1998	The new pharmaceutical policy in Italy RePEc:eee:hepoli:v:46:y:1998:i:1:p:21-41 [Citation Analysis]	7

Citing documents used to compute impact factor 33:

Year	Title	See
2011	Relative effectiveness and the European pharmaceutical market RePEc:spr:eujhec:v:12:y:2011:i:2:p:97-102	[Citation Analysis]
2011	Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: A time-series analysis for France 1998–2010 RePEc:eee:hepoli:v:102:y:2011:i:2:p:159-169	[Citation Analysis]
2011	In the shadow illegal markets and economic sociology RePEc:zbw:mpifgd:119	[Citation Analysis]
2011	Competition leverage: How the demand side affects optimal risk adjustment RePEc:cpb:discus:181	[Citation Analysis]
2011	Competition Leverage: How the Demand Side Affects Optimal Risk Adjustment RePEc:dgr:kubcen:2011071	[Citation Analysis]
2011	A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention RePEc:eee:hepoli:v:101:y:2011:i:3:p:290-299	[Citation Analysis]
2011	Public and private funding of general practice services for children and adolescents in New Zealand RePEc:eee:hepoli:v:103:y:2011:i:1:p:24-30	[Citation Analysis]
2011	The effects of medical factors on transfer deficits in Public Assistance in Japan: a quantile regression analysis RePEc:kap:ijhcfe:v:11:y:2011:i:4:p:287-307	[Citation Analysis]
2011	A study on the socio-economic determinants of suicide: Evidence from 13 European OECD countries RePEc:pra:mprapa:29075	[Citation Analysis]
2011	Socio-economic determinants of suicide in Japan RePEc:eee:soceco:v:40:y:2011:i:6:p:723-731	[Citation Analysis]
2011	Comparative analysis of delivery of primary eye care in three European countries RePEc:zbw:udewwd:189	[Citation Analysis]
2011	Out-of-pocket expenditures for hospital care in Iran: who is at risk of incurring catastrophic payments? RePEc:kap:ijhcfe:v:11:y:2011:i:4:p:267-285	[Citation Analysis]
2011	Changing patient consultation patterns in primary care: an investigation of uptake of the Minor Ailments Service in Scotland RePEc:eee:hepoli:v:99:y:2011:i:1:p:44-51	[Citation Analysis]
2011	Comparison of healthcare costs between local and immigrant HIV populations living in Southern Alberta, Canada RePEc:eee:hepoli:v:103:y:2011:i:2:p:124-129	[Citation Analysis]
2011	Shifting the risk in pricing and reimbursement schemes? A model of risk-sharing agreements for innovative drugs RePEc:gea:wpaper:2/2011	[Citation Analysis]
2011	The expansion of public health insurance and the demand for private health insurance in rural China RePEc:eee:chieco:v:22:y:2011:i:1:p:28-41	[Citation Analysis]
2011	A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention RePEc:eee:hepoli:v:101:y:2011:i:3:p:290-299	[Citation Analysis]
2011	Medical technology procurement in Europe: A cross-country comparison of current practice and policy RePEc:eee:hepoli:v:100:y:2011:i:1:p:43-50	[Citation Analysis]
2011	Introduction and uptake of new medical technologies in the Australian health care system: A qualitative study RePEc:eee:hepoli:v:102:y:2011:i:2:p:152-158	[Citation Analysis]
2011	Urbanization and the utilization of outpatient services under National Health Insurance in Taiwan RePEc:eee:hepoli:v:103:y:2011:i:2:p:236-243	[Citation Analysis]
2011	Technical efficiency in primary health care: does quality matter? RePEc:spr:eujhec:v:12:y:2011:i:2:p:115-125	[Citation Analysis]
2011	An analysis of hospital capital planning and financing in three European countries: Using the principal-agent approach to identify the potential for economic problems RePEc:eee:hepoli:v:99:y:2011:i:2:p:158-166	[Citation Analysis]
2011	Incentives in primary care and their impact on potentially avoidable hospital admissions RePEc:spr:eujhec:v:12:y:2011:i:4:p:297-309	[Citation Analysis]
2011	The role of GP’s compensation schemes in diabetes care: evidence from panel data RePEc:bol:bodewp:wp766	[Citation Analysis]
2011	Does Better Disease Management in Primary Care Reduce Hospital Costs? RePEc:chy:respap:65cherp	[Citation Analysis]
2011	Does better disease management in primary care reduce hospital costs? Evidence from English primary care RePEc:eee:jhecon:v:30:y:2011:i:5:p:919-932	[Citation Analysis]
2011	Direct-to-consumer advertising (DTCA) for prescription drugs: Consumers attitudes and preferences concerning its regulation in South Korea RePEc:eee:hepoli:v:101:y:2011:i:3:p:260-268	[Citation Analysis]
2011	Health policies for migrant populations in three European countries: England; Italy and Spain RePEc:eee:hepoli:v:101:y:2011:i:1:p:70-78	[Citation Analysis]
2011	Diffusion of medical technology: The role of financing RePEc:eee:hepoli:v:100:y:2011:i:1:p:51-59	[Citation Analysis]
2011	Health technology prioritization: Which criteria for prioritizing new technologies and what are their relative weights? RePEc:eee:hepoli:v:102:y:2011:i:2:p:126-135	[Citation Analysis]
2011	Health care prioritization in ageing societies: Influence of age, education, health literacy and culture RePEc:eee:hepoli:v:100:y:2011:i:2:p:219-233	[Citation Analysis]
2011	Evaluation and equity audit of the domestic radon programme in England RePEc:eee:hepoli:v:102:y:2011:i:1:p:81-88	[Citation Analysis]
2011	Do expert patients get better treatment than others? Agency discrimination and statistical discrimination in obstetrics RePEc:eee:jhecon:v:30:y:2011:i:1:p:163-180	[Citation Analysis]

Cites in year: CiY